BioCentury
ARTICLE | Company News

Antitope, ConsulTech GmbH, Coriolis PharmaService GmbH, Covance, FGK Clinical Research GmbH, Pieris, Fujifilm, Innsbruck Medical University, Radboud University

October 24, 2011 7:00 AM UTC

The Eurocalin Consortium received €6 million ($8.3 million) from the EU's seventh Framework Program (FP7) to develop Pieris' PRS-080 to treat anemia. Pieris will lead development of PRS-080, an antic...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article